CESSATION of gonadotropin-releasing hormone antagonist (GnRH-ant) on trigger day in the GnRH-ant protocol improves the ...
Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...
A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback